Ivd Reagents Market Report 2024 (Global Edition)

Global Ivd Reagents Market Report 2024 Market Size Split by Type (Antibodies, Oligonucleotides, Nucleic Acid Probes, Purified Proteins or Peptides, Others), by Technology (Immunoassay/Immunochemistry,...

Ivd Reagents Market Report Description

We have various report editions of Ivd Reagents Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Ivd Reagents Market Insights Video

Company Profile:

Abbott 

Abbott is the US based healthcare company. The company is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments including pharmaceutical products, diagnostic products, nutritional products, and medical devices. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors. 

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories Inc manufactures several products, which are used in several end-user sectors such as university and research institutions, hospitals, public health, and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories. The company offers next generation DNA sequencing methods, digital PCR, assay procedures, screening tools and other. The company offers its products under various division such as life science research, clinical diagnostic, process separation, food science and corporate.

Top Companies Market Share in Ivd Reagents Industry: (In no particular order of Rank)

• Becton
• Dickinson and Company
• Merck KGaA
• Thermo Fisher Scientific
• Bio-Rad Laboratories Inc
• Beckman Coulter Inc
• LGC Biosearch Technologies
• BioLegend Inc
• InBios International Inc
• LakePharma Inc
• Bioline
• Abcam plc
• The Binding Site Group Ltd
• SDIX LLC
• DIACLONE SAS
• Bio-Techne Corporation
• Agilent Technologies Inc
• Hologic Inc
• Bio-Synthesis Inc
• RayBiotech Inc
• Sino Biological Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Ivd Reagents Market Regional Analysis

Region and country analysis section of Ivd Reagents Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Ivd Reagents market.

 

The current report Scope analyzes Ivd Reagents Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Ivd Reagents Market Analysis

IVD Reagents Market, by Type

Antibodies

The Antibodies segment Revenue in IVD Reagents will be USD 25.89 Billion by 2029.

IVD antibodies are commonly employed in immunology procedures such as immunonephelometry and sandwich ELISA. IVD antibodies are distinctive diagnostic instruments used in clinical diagnosis and scientific investigations. These IVD antibodies aid medical practitioners in early illness detection and diagnosis, enabling them to start effective treatment regimens

Oligonucleotides

The FDA authorized oligonucleotide-based treatments some years ago. Due to this enhanced activity, it is essential to use synthetic oligonucleotides that are produced according to GMP standards for pre-clinical testing. The need for improved oligonucleotide process control for IVD increases as a result of this.

Nucleic Acid Probes

A microbe's DNA or RNA contains specific nucleotide sequences that may be detected using nucleic acid probes. These specific nucleotide signatures serve as substitutes for the actual existence of the microorganism. For IVD, they are employed. The examination of DNA and RNA molecules in clinical samples is now possible because of the development of several novel nucleic acid-based diagnostic tools or tests. As a result, demand for IVD reagents increases.

Purified Proteins or Peptides

Peptide-based IVD is particularly useful for detecting viral illnesses, heart ailments, cancer, and immunological disorders. Antigen-antibody interactions are the foundation for methods like the enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, enzyme-linked immune sorbent spot (ELISPot), and Western blot, where peptides are important constituents acting as antigens. Diagnostic assays are frequently based on these interactions. These tests are used to assess a biomarker molecule's quantity or existence.

Others

Several other reagents such as blocking agents, detergents, surfactants, wetting agents, buffers, stabilizers, purified water, dyes, standards & controls, enzymes, cell culture reagents, and anti-coagulants are used as reagents in IVD.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Ivd Reagents Industry. Request a Free Sample PDF!

IVD Reagents Market, by Technology

Immunoassay/Immunochemistry 

The Immunoassay/Immunochemistry segment Revenue will be USD 18.57 Billion by 2029.

In vitro, diagnostic, (IVD) immunoassays can improve the quality of healthcare and enable more accurate diagnosis. IVD immunoassays are used to detect a wide range of diseases and have become the most essential tool worldwide to help reduce the spread of viral diseases. Additionally, immunohistochemistry is used for IVD testing of tissue biopsy material, which must be taken from the patient. Recent advancements in microbiology and immunochemistry have provided cost-effective diagnostic tools for faster and more accurate results.

Biochemistry/Clinical Chemistry

Clinical chemistry is the biochemical analysis of body fluids that usually uses chemical reactions to determine the levels of chemical compounds in bodily fluids. Several chemical tests are used to detect and quantify different compounds in blood and urine which are the most commonly tested specimens in clinical chemistry. IVD reagents for clinical chemistry testing relied basically on absorbance measurement with light generated by halogen lamps. Reagents apply to IVDs that are intended to be used to diagnose clinical infections that cause serious diseases with a high risk of transmission within the geriatric population.

Molecular Diagnostics

Molecular diagnostics refers to a series of procedures that are used to analyze biomarkers in the genome and proteome. These tests manage specific sequences in nucleic acids, as well as how cells express genes as proteins. This information can be used to diagnose and monitor disease, and determine the best-suited therapies for each patient. In vitro diagnostics (IVDs) are tests executed on samples taken from the human body, that continue to pave the way for precision medicine by exploiting molecular testing. Results can be used in concordance with other clinical data, such as histology and immunohistochemistry, to gain a complete and unique picture of an individual patient's health. Clinical applications for molecular diagnostics and IVD testing include oncology, genetic disease screening, pharmacogenomics, and more.

Microbiology

The workflow of the IVD Module combines the identification of significant pathogens with automated subsequent detection of certain marker peaks. A large number of microbe species can be quickly and accurately identified using Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) mass spectrometry, and strong software handles rapid typing and result reporting automatically. This raises the demand for IVD reagents

Hematology

Hematology reagents are used in automated analyzers to measure the number of red blood cells (RBCs or erythrocytes), white blood cells (WBCs or leucocytes), and platelets per unit volume in a venous blood sample. Due to their excellent quality, lengthy shelf life, and batch-to-batch uniformity, they are frequently utilized for IVD. It has the advantage of precise and repeatable output. In order to assist hematological examinations, these characteristics make sure that end users see incredibly vivid photos and long-term color stability.

Coagulation/Hemostasis

Hemostasis is the process through which a blood vessel stops bleeding. It is a procedure with several connected phases. Today, the In Vitro Diagnostic (IVD) industry is driven to innovate in the disciplines of hemostasis and thrombosis with employees dedicated to research and development (R&D) and a level of investment above average.

Urinalysis

A urinalysis is a urine examination. A variety of diseases and conditions, including kidney disease, diabetes, and urinary tract infections, are detected and treated with IVD urinalysis. A urinalysis involves examining the color, consistency, and composition of urine. Today's urine test strips are a cutting-edge, simple, and effective medical instrument. Urine test strips are an excellent tool for diagnosing and treating a variety of disorders.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Ivd Reagents Use Segment Analysis

Research Use Only

The Research Use Only segment Revenue in IVD Reagents will be USD 19.13 Billion by 2029.

With increased financing from different government organizations, the complexity of clinical trials, and higher drug failure rates in early phase studies, R&D activities in academic institutions and government research institutes have greatly risen during the previous two to three decades. These initiatives are transforming how research is conducted. As a result, there is an increasing need for IVD reagents.

Clinical Use

The necessity of novel therapeutics has increased due to the rising worldwide prevalence of acute and chronic infectious illnesses and the aging population. The need for IVD reagents grows as a result. In vitro, diagnostic techniques employ IVD reagents for patient diagnosis, monitoring, and therapy

• Research Use Only
• Clinical Use

Ivd Reagents End user Segment Analysis

IVD Manufacturers

The IVD Manufacturers' segment Revenue in IVD Reagents will be USD 28.98 Billion by 2029.
IVD reagents are often used for patient diagnosis, monitoring, and therapy by IVD producers. These items are designed to be used in the evaluation of human body specimen samples. It may also be utilized in a wide range of devices, from simple lab equipment to compact, portable testing.

Reference Laboratories

Reference labs are typically private, for-profit establishments that provide both regular and specialized testing in large volumes. End-use items for diagnostic testing, such as reagent kits, calibrators, control materials, sample diluents, etc., are considered to be included in this definition. These facilities often employ IVD reagents.

Academic and Research Institutes

Academic and research institutes are generally involved in numerous research activities. These research activities often needed in vitro diagnostics. Nowadays research activities are growing dramatically which leads to the rising demand for IVD reagents.

Hospital Laboratories

There is a broad range of in-vitro diagnostics (IVDs), from self-tests for pregnancy and blood glucose tests for diabetics, to sophisticated diagnoses performed in hospital laboratories. The tests themselves can be performed on a variety of instruments ranging from small, handheld tests to complex laboratory instruments. For these tests, IVD reagents play an important role in accurate results.

• IVD Manufacturers
• Reference Laboratories
• Academic and Research Institutes
• Hospital Laboratories

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Detail

Kalyani Raje

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

ResearchGate Profile: https://www.researchgate.net/profile/Kalyani-Raje

An optimistic Senior Research Analyst with years of experience in competitive assessment and business consulting. A seasoned professional and subject-matter expert (SME) in the Automobile and transportation vertical.

Author's Conclusion